Involvement of capsular polysaccharide via a TLR2/NF-κB pathway in Vibrio vulnificus-induced IL-8 secretion of human intestinal epithelial cells

被引:18
作者
Lee, Byung Cheol [1 ]
Kim, Myun Soo [1 ]
Choi, Sang Ho [2 ]
Kim, Tae Sung [1 ]
机构
[1] Korea Univ, Sch Life Sci & Biotechnol, Div Life Sci, Seoul 136701, South Korea
[2] Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Seoul 151921, South Korea
关键词
Vibrio vulnificus; capsular polysaccharide; interleukin-8; Toll-like receptor 2; nuclear factor-kappa B; intestinal epithelial cell; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; HELICOBACTER-PYLORI; GENE-EXPRESSION; P38; MAPK; IN-VITRO; IDENTIFICATION; ACTIVATION; VIRULENCE; PATHOGENESIS;
D O I
10.3892/ijmm_00000380
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In a previous study. we reported that a wbpP gene mutation in Vibrio vulnificus was significantly impaired in its ability to synthesize surface capsular polysaccharide (CPS) In this study, we evaluated the functions of the V. vulnificus capsular polysaccharide on interleukin (IL)-8 production, as well as its underlying mechanisms in human intestinal epithelial cells. The CPS-defective wbpP mutant induced significantly lower levels of IL-8 production, IL-8 gene promoter activation and NF-kappa B activity in INT-407 cells than was noted with the wild-type or wbpP-complemented V, vulnificus. The expression levels of Toll-like receptor (TLR)2 mRNA and protein were also found to be lower in INT-407 cells infected with the CPS-defective wbpP mutant than ill those cells infected with the wild-type or the wbpP-complemented strains Additionally. the treatment of INT-407 cells with anti-TLR2 antibody proved to significantly block IL-8 production and NF-kappa B minimal promoter activity induced by the wild-type or the wbpP-complemented strains Furthermore. purified V vulnificus CPS was found to significantly induce IL-8 production and NF-kappa B activation. both of which were inhibited upon the addition of the anti-TLR2 antibody. Taken together. these results demonstrate that V vulnificus capsular polysaccharide is involved Ill the induction of IL-8 production of human Intestinal Cl)epithelia cells via a TI-R2/NF-kappa B-dependent pathway
引用
收藏
页码:581 / 591
页数:11
相关论文
共 40 条
[1]   TLR signaling in the gut in health and disease [J].
Abreu, MT ;
Fukata, M ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4453-4460
[2]   The lipopolysaccharide O side chain of Vibrio vulnificus serogroup E is a virulence determinant for eels [J].
Amaro, C ;
Fouz, B ;
Biosca, EG ;
MarcoNoales, E ;
Collado, R .
INFECTION AND IMMUNITY, 1997, 65 (06) :2475-2479
[3]  
BLEANGER M, 1999, MICROBIOLOGY, V145, P3505
[4]   Classification of Vibrio vulnificus strains by the carbohydrate composition of their capsular polysaccharides [J].
Bush, CA ;
Patel, P ;
Gunawardena, S ;
Powell, J ;
Joseph, A ;
Johnson, JA ;
Morris, JG .
ANALYTICAL BIOCHEMISTRY, 1997, 250 (02) :186-195
[5]   Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS [J].
Dueñas, AI ;
Orduña, A ;
Crespo, MS ;
García-Rodríguez, C .
INTERNATIONAL IMMUNOLOGY, 2004, 16 (10) :1467-1475
[6]   Relation of capsular polysaccharide production and colonial cell organization to colony morphology in Vibrio parahaemolyticus [J].
Enos-Berlage, JL ;
McCarter, LL .
JOURNAL OF BACTERIOLOGY, 2000, 182 (19) :5513-5520
[7]   A role for tumor necrosis factor-alpha in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction [J].
Espat, NJ ;
Auffenberg, T ;
Abouhamze, A ;
Baumhofer, J ;
Moldawer, LL ;
Howard, RJ .
ANNALS OF SURGERY, 1996, 223 (04) :428-433
[8]   Vibrio vulnificus IlpA-induced cytokine production is mediated by toll-like receptor 2 [J].
Goo, Sung Young ;
Han, Yang Soo ;
Kim, Woo Hyang ;
Lee, Kyu-Ho ;
Park, Soon-Jung .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (38) :27647-27658
[9]   PURIFICATION AND CHARACTERIZATION OF AN EXTRACELLULAR CYTOLYSIN PRODUCED BY VIBRIO-VULNIFICUS [J].
GRAY, LD ;
KREGER, AS .
INFECTION AND IMMUNITY, 1985, 48 (01) :62-72
[10]  
Hallett WHD, 2004, CELL MOL IMMUNOL, V1, P12